3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Breast Neoplasms
3
Melanoma
2
Colorectal Neoplasms
2
Untreated Resectable Pancreatic Adenocarcinoma
1
Resectable Localized Prostate Cancer
1
Prostatic Neoplasms
1
Prostate Cancer Recurrent
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Neoplasm, Residual
1
Liver Neoplasms
1
Klatskin Tumor
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Glioma
1
Gastrointestinal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Adenocarcinoma
1
Interventions
pembrolizumab
2
enfortumab vedotin
2
Tablets
2
Exercise
2
Acupuncture Therapy
2
nicotinamide-beta-riboside
1
Vitamin B Complex
1
Thioctic Acid
1
Tadalafil
1
Single Person
1
Rosuvastatin Calcium
1
Omeprazole
1
Memantine
1
Massage
1
Lenalidomide
1
Gloves, Surgical
1
Fish Oils
1
Fenofibrate
1
Exercise Therapy
1
Dexamethasone
1
Cryotherapy
1
Corn Oil
1
Control Groups
1
Bortezomib
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Peripheral Nervous System Diseases
×
Hydroxychloroquine
×
1 year
×
Clear all
No trials found.